Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Endosc. May 16, 2012; 4(5): 157-161
Published online May 16, 2012. doi: 10.4253/wjge.v4.i5.157
Published online May 16, 2012. doi: 10.4253/wjge.v4.i5.157
Tham et al 1998 | Buenoet al 2003 | Togawa et al 2008 | Rogart et al 2008 | Ridtitid et al 2010 | Cho et al 2011 | |
No. of patients | 152 | 592 | 95 | 90 | 154 | 583 |
No. of patients with SEMS occlusion (uncovered/covered) | 44 (44/0) | 34 (34/0) | 40 (40/0) | 27 (23/4) | 32 (22/10) | 77 (30/47) |
Tumor ingrowth (%) | 28 (63.6) | 20 (58.8) | 36 (90) | 19 (70.4) | 25 (78.1) | 53 (68.8) |
Tumor overgrowth (%) | 3 (6.8) | 9 (26.5) | 3 (7.5) | 3 (11.1) | 3 (9.4) | 9 (11.7) |
Sludge/debris (%) | 8 (18.2) | 5 (14.7) | 1 (2.5) | 5 (18.5) | 51 (15.6) | 8 (10.4) |
Others | Hyperplasia 3 | - | - | - | Migration 4 | Compression/blood clot/migration 7 |
Undefined 2 |
- Citation: Ridtitid W, Rerknimitr R. Management of an occluded biliary metallic stent. World J Gastrointest Endosc 2012; 4(5): 157-161
- URL: https://www.wjgnet.com/1948-5190/full/v4/i5/157.htm
- DOI: https://dx.doi.org/10.4253/wjge.v4.i5.157